These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2406991)

  • 21. [n or more in clinical trials? Zelen's models for randomization].
    Taube A
    Lakartidningen; 1994 Mar; 91(10):977-82. PubMed ID: 8139323
    [No Abstract]   [Full Text] [Related]  

  • 22. [Types of clinical research: the most important errors of design and interpretation].
    Gómez de la Cámara A
    Arch Bronconeumol; 1999 Feb; 35 Suppl 1():9-13. PubMed ID: 10326644
    [No Abstract]   [Full Text] [Related]  

  • 23. Alternatives to randomized clinical trials.
    Ellison GW; Mickey MR; Myers LW
    Neurology; 1988 Jul; 38(7 Suppl 2):73-5. PubMed ID: 3290718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statistical methods in clinical trials.
    Gebski VJ; Keech AC
    Med J Aust; 2003 Feb; 178(4):182-4. PubMed ID: 12580749
    [No Abstract]   [Full Text] [Related]  

  • 25. Medscape psychopharmacology today: understanding clinical trials in context.
    Kramer TA
    MedGenMed; 2003 Oct; 5(4):2. PubMed ID: 14745349
    [No Abstract]   [Full Text] [Related]  

  • 26. Interpreting HIV clinical trials.
    Glesby MJ
    AIDS Clin Care; 1999 Jul; 11(7):58-9. PubMed ID: 11366435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The scientific basis of clinical trials: statistical aspects.
    Gehan EA
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2587-90. PubMed ID: 9815661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A step-by-step approach to the evaluation of clinical studies with therapeutic or preventive objectives.
    Vergara CM; Wang F
    Conn Med; 2003 Apr; 67(4):195-203. PubMed ID: 12760079
    [No Abstract]   [Full Text] [Related]  

  • 29. [The limits of controlled clinical studies: the case of rheumatology].
    Portioli I
    Ann Ital Med Int; 2000; 15(1):39-46. PubMed ID: 10842890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quality of methodology and reporting of randomized controlled trials of acupuncture for obesity].
    Liu XM; Zhang MM; Du L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):192-4. PubMed ID: 15171560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients.
    Freidlin B; Simon R
    Clin Cancer Res; 2005 Nov; 11(21):7872-8. PubMed ID: 16278411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recent progress of clinical trials in urologic oncology].
    Hinotsu S
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):188-92. PubMed ID: 16484854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Research methodology: A guarantee for progress in knowledge about infections].
    Carballo Alvarez F
    Rev Esp Quimioter; 2001 Jun; 14(2):126-37. PubMed ID: 11704767
    [No Abstract]   [Full Text] [Related]  

  • 36. David Moher, MSc The CONSORT Guidelines: improving the quality of research. Consolidated Standards of Reporting Trials. Interview by Bonnie Horrigan.
    Moher D
    Altern Ther Health Med; 2002; 8(3):103-8. PubMed ID: 12017485
    [No Abstract]   [Full Text] [Related]  

  • 37. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter: Assessment of papers of clinical trials.
    Nyberg G
    Med J Aust; 1974 Sep; 2(10):381. PubMed ID: 4608038
    [No Abstract]   [Full Text] [Related]  

  • 39. In defense of pharmacoepidemiology--embracing the yin and yang of drug research.
    Avorn J
    N Engl J Med; 2007 Nov; 357(22):2219-21. PubMed ID: 18046025
    [No Abstract]   [Full Text] [Related]  

  • 40. Designing studies that answer questions.
    Shott S
    J Am Vet Med Assoc; 2011 Jan; 238(1):55-8. PubMed ID: 21194321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.